Effect of camazepam (SB-5833), a new antianxious drug, on cardiac contractility and coronary hemodynamics.
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D001011:Aorta / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002219:Carbamates / Q000494:pharmacology; D002302:Cardiac Output / Q000187:drug effects; D002707:Chlordiazepoxide / Q000494:pharmacology; D003326:Coronary Circulation / Q000187:drug effects; D003975:Diazepam / Q000031:analogs & derivatives / Q000494:pharmacology; D004285:Dogs; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D014655:Vascular Resistance / Q000187:drug effects
D014151:Anti-Anxiety Agents; D002219:Carbamates; D002707:Chlordiazepoxide; D003975:Diazepam